In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum

BACKGROUND: Schistosomiasis is a debilitating neglected tropical disease that affects approximately 190 million people around the world. Praziquantel (PZQ) is the only drug available for use against all Schistosoma species. Although PZQ has a high efficacy, recognized concerns have prompted the deve...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Parasit Vectors
Hlavní autoři: Wang, Xiaoli, Yu, Dan, Li, Chunxiang, Zhan, Tingzheng, Zhang, Tingting, Ma, Huihui, Xu, Jing, Xia, Chaoming
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2019
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6500042/
https://ncbi.nlm.nih.gov/pubmed/31053083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-019-3442-7
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky